Imports weaken Indian pharma – The Hindu
New medicines are generally under patent protection, preventing Indian companies from producing affordable generics/biosimilars. | Photo Credit: Getty Images/iStockphoto Ensuring the affordability of pharmaceuticals is essential for controlling healthcare costs, especially in India, where out-of-pocket health expenditures accounted for nearly 47.1% of the total health expenditure in 2021. While the Drugs Price Control Order, 2013, … Read more
